MBRS IMSD Program at Louisiana State University

路易斯安那州立大学 MBRS IMSD 项目

基本信息

项目摘要

DESCRIPTION (provided by applicant): An ambitious and innovative MBRS IMSD program at Louisiana State University would train twenty upper-level underrepresented minority undergraduate Scholars per year for careers as biomedical researchers. LSU has established a national reputation for increasing the numbers of underrepresented doctoral students entering academics and industry, particularly in the Department of Chemistry. The current goal is to extend this success to include the training of minority undergraduates in areas of interest to the NIH. A number of new initiatives and programs have recently been established at LSU, aimed at the education and retention of minority undergraduates particularly in the STEM (science, technology, engineering and mathematics) fields. The proposed IMSD program would service the needs of undergraduates with a specific interest in advanced biomedical research training. A select group of IMSD Student Scholars would be matched with faculty research preceptors according to their interest. They would work in the preceptors' laboratory for two academic years, receiving wages. Eight measurable goals would be used for program evaluation to meet NIH and institutional objectives: (i) 20 (10 junior and 10 LSU senior undergraduate) IMSD Scholars perform 15 hours per week of biomedical research for 9 (academic) months per year, as monitored by student time sheets and semester research progress reports, approved and signed by their respective preceptors, (ii) presentation of at least one lecture or poster of the student's research at a major regional or national scientific meeting and attendance at a second meeting, (iii) coauthorship of at least one peer-reviewed publication by at least 90% of the students, (iv) at least 95% attendance at IMSD meetings, seminars and relevant events, (v) selection and invitation by the IMSD students of three nationally renowned scientists per year who specialize in areas of interest to the students and the program, (vi) each of the IMSD Scholars maintaining at least a 3.0 GPA for full-time loads, (vii) the IMSD Scholars having at least a 90% graduation rate within four years of enrollment at LSU, (viii) the IMSD Scholars attaining at least a 90% success rate in graduate or professional school placement and/or biomedical research employment immediately upon graduation. The students would meet once a week during each semester in a seminar held by the PI/Project Director to address student needs and concerns and for educational enhancement activities. Activities would include presentations by LSU faculty and graduate students on biomedical research, the fine points of presentations of posters and lectures, info on standardized testing, selecting and applying to graduate school, laboratory safety, bioethics and biomedical issues of specific relevance to minority groups, financial aid and other relevant programs.
描述(由申请人提供):路易斯安那州立大学雄心勃勃且创新的 MBRS IMSD 项目每年将培训 20 名高水平的代表性不足的少数族裔本科学者,以从事生物医学研究人员的职业。路易斯安那州立大学因增加进入学术界和工业界(尤其是化学系)的博士生数量而闻名全国。目前的目标是将这一成功扩大到在 NIH 感兴趣的领域对少数族裔本科生进行培训。路易斯安那州立大学最近制定了许多新举措和计划,旨在教育和保留少数族裔本科生,特别是在 STEM(科学、技术、工程和数学)领域。拟议的 IMSD 项目将满足对高级生物医学研究培训有特定兴趣的本科生的需求。一组选定的 IMSD 学生学者将根据他们的兴趣与教师研究导师进行匹配。他们将在导师实验室工作两个学年,领取工资。将使用八个可衡量的目标进行项目评估,以满足 NIH 和机构目标: (i) 根据监测,20 名(10 名大三本科生和 10 名路易斯安那州立大学高年级本科生)IMSD 学者每年进行 9(学术)个月的生物医学研究,每周进行 15 小时由各自的导师批准和签署的学生时间表和学期研究进度报告,(ii) 在主要的地区或国家科学会议上展示至少一篇学生研究的讲座或海报,以及出席第二次会议,(iii) 至少 90% 的学生共同撰写至少一份同行评审出版物,(iv) 至少 95% 的学生出席 IMSD 会议、研讨会和相关活动,(v) 选择和邀请由每年三名全国知名科学家的 IMSD 学生组成,他们专门研究学生和项目感兴趣的领域,(vi) 每位 IMSD 学者的全日制学习 GPA 至少保持 3.0,(vii) IMSD 学者在路易斯安那州立大学入学后四年内毕业率至少为 90%,(viii) IMSD 学者在毕业后立即在研究生或专业学校安置和/或生物医学研究就业中获得至少 90% 的成功率。每个学期,学生每周都会参加一次由 PI/项目总监举办的研讨会,以解决学生的需求和担忧,并开展教育强化活动。活动将包括路易斯安那州立大学教师和研究生关于生物医学研究的演讲、海报和讲座演讲的要点、标准化测试的信息、研究生院的选择和申请、实验室安全、与少数群体具体相关的生物伦理学和生物医学问题,财政援助和其他相关计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria Da Graca Vicente其他文献

Maria Da Graca Vicente的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

PLA2G4B调控角质形成细胞脂肪酸代谢上调CCL20表达加重银屑病的机制研究
  • 批准号:
    82304003
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于单细胞核转录组测序揭示围产期奶牛脂肪过度动员组织微环境及其关键驱动因子
  • 批准号:
    32302943
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
脂相关巨噬细胞CA12介导铁死亡在脂肪肝相关肝癌的作用机制研究
  • 批准号:
    82302583
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
TCF3诱导N1型中性粒细胞分化导致脂肪肝移植后失功的机制研究
  • 批准号:
    82370673
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
苯丙氨酰tRNA合成酶α(FARSA)调控脂肪细胞脂质代谢的机制研究
  • 批准号:
    82300954
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Household Air Pollution, Adiposity, and Cardiorenal Disease Risk in Children
家庭空气污染、肥胖和儿童心肾疾病风险
  • 批准号:
    10739062
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Exosomes and insulin action in metabolically healthy and unhealthy obesity
外泌体和胰岛素在代谢健康和不健康肥胖中的作用
  • 批准号:
    10721302
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Prenatal Exposure to Metal Mixtures: Childhood Adiposity and Adipokines
产前接触金属混合物:儿童肥胖和脂肪因子
  • 批准号:
    10387995
  • 财政年份:
    2022
  • 资助金额:
    $ 2.4万
  • 项目类别:
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment
PPARg 乙酰化抑制剂预防和治疗糖尿病的临床前验证
  • 批准号:
    10580851
  • 财政年份:
    2021
  • 资助金额:
    $ 2.4万
  • 项目类别:
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment
PPARg 乙酰化抑制剂预防和治疗糖尿病的临床前验证
  • 批准号:
    10430186
  • 财政年份:
    2021
  • 资助金额:
    $ 2.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了